The End of a Long and Shameful Debacle
Prof Michael Frass' infamous cancer study will be retracted.
Background
In November 2020, Frass et al published a study that prompted confusion and concern. The study's conclusions were:
- QoL improved significantly in the homeopathy group compared with placebo.
- Survival was significantly longer in the homeopathy group versus placebo and control.
- A higher QoL might have contributed to the prolonged survival.
The study suggests that homeopathy positively influences not only QoL but also survival.
Criticism and Concerns
On 7 October 2020, concerns about this research were raised in a blog post with 13 questions about the trial. Many more in-depth critiques have been published by colleagues, including:
- A thorough analysis of Prof M. Frass' recent homeopathy trial casts serious doubts on its reliability.
Author's summary: Frass' cancer study retracted due to concerns.
More News
- Where the Chefs Eat: Skye McAlpine’s Venice
- CHEFS (@chefs_podcast) - Instagram photos and videos
- The first week of testimony in Brian Walshe’s murder trial is over. Here are takeaways from Day 5
- Solidarity on Trial in Greece
- Warriors 99-94 Cavaliers (Dec 6, 2025) Game Recap
- Oil spills and technological cooperation for their prevention
- Spill and pollution response
- Golden State Warriors vs Cleveland Cavaliers | Live Play-By-Play & Reactions
- Spillcontrol – Spill Control
- Netanyahu: Won’t quit politics for pardon in corruption trial